On the liver capsule when combined Philips Xuezhikang treatment of hyperlipidemia in nonalcoholic fatty liver disease.docVIP

 PAGE \* MERGEFORMAT 9 On the liver capsule when combined Philips Xuezhikang treatment of hyperlipidemia in nonalcoholic fatty liver disease [Keywords:] When Philips liver Ning; Xuezhikang, non-alcoholic fatty liver disease, hyperlipidemia With the improvement of living standards, obesity, diabetes, hypertension, high cholesterol and other groups increased, fatty liver disease has become a common and frequently-occurring disease, particularly non-alcoholic fatty liver disease (Non-alcoholic fatty liver diease, NAFLD) in the pathogenesis rates rise, become more than viral hepatitis and alcoholic liver disease, as most of the major cause of cryptogenic cirrhosis. but there is no ideal treatment for NAFLD treatment. The author of the liver when the Philips joint lipids Ning NAFLD on Treatment of patients with combined hyperlipidemia preliminary clinical observations. 1 Data and methods 1.1 General information 52 patients from May 2003 -2006 in March medical clinic or hospital ward bile, the history and related to inspection and analysis, combined hyperlipidemia diagnosed with NAFLD. including 23 males, 29 females, aged 18 to 67 years, average 45.7 years old. by stratified random method randomly divided into 2 groups: A group of 30 patients, 12 cases of male , female 18 cases, B group, 22 cases, male 10 cases, 12 cases of female patients between .2 age, gender, body mass index (BMI), blood glucose, blood lipids, liver function and insulin resistance index constitutes a comparable diagnostic .1.2 Standard ① According to the Chinese Medical Association Society of fatty liver and liver disease alcoholic liver disease study group developed a non-alcoholic fatty liver diagnostic criteria [1], fatty liver histological score proposed by Brunt and other criteria to evaluate [2], ② high fat hyperlipidemia diagnostic criteria developed with reference to China in 1997, prevention and treatment of dyslipidemia recommendations [3], abnormal blood lipids by dietary adjustm